Tenet Healthcare Corporation — FY2013 Form 10-K
Business context and reporting period. The filing covers the year ended December 31, 2013; the fourth quarter is included, but this is an annual report, not a standalone Q4 filing. Tenet operates hospitals, outpatient facilities, health plans and Conifer, its healthcare business-services subsidiary. On October 1, 2013, Tenet acquired Vanguard, adding 28 hospitals, 39 outpatient centers and five health plans. Accordingly, reported 2013 results include Vanguard for only three months, and year-over-year comparisons are affected by the acquisition.
Financial and operating highlights
- Revenue: FY net operating revenues were $11.102 billion, up from $9.119 billion in 2012; revenue before doubtful-account provision was $12.074 billion. The doubtful-account provision rose to $972 million from $785 million. Q4 net operating revenues were $3.885 billion.
- Profitability: Operating income was $663 million versus $749 million; operating margin fell to 6.0% from 8.2%. Net loss attributable to Tenet common shareholders was $134 million, or $1.32 per diluted share, compared with net income of $141 million, or $1.30 per diluted share, in 2012. Q4 common-shareholder loss was $24 million, or $0.24 per diluted share.
- Adjusted EBITDA: $1.342 billion, compared with $1.203 billion in 2012; margin declined to 12.1% from 13.2%. This is a non-GAAP measure.
- Cash flow and investment: Operating cash flow was $589 million versus $593 million. Investing cash outflow was $2.164 billion, including $1.515 billion for acquisitions, net of cash acquired, and $691 million of capital expenditures. Financing cash inflow was $1.324 billion.
- Liquidity and debt: Year-end cash was $113 million, down from $364 million; working capital was $782 million versus $918 million. Long-term debt was $10.839 billion, including $149 million current; the filing reports net debt to trailing Adjusted EBITDA of 6.0x using Vanguard’s trailing results. Revolver availability was $406 million, with $405 million borrowed and $189 million of letters of credit outstanding.
- Operating trends: Same-hospital FY admissions fell 3.1%, patient days fell 2.3%, and outpatient visits rose 2.9%; same-hospital net operating revenue increased 6.2%. Q4 same-hospital admissions decreased 2.3%, while outpatient visits increased 3.3%. These same-hospital figures exclude Vanguard.
Material changes versus prior period
- Vanguard materially expanded the business and balance sheet: total assets rose to $16.130 billion from $9.044 billion, while long-term debt rose to $10.839 billion from $5.252 billion.
- The $348 million loss on early debt extinguishment was a major unusual expense in 2013, compared with $4 million in 2012. Interest expense rose to $474 million from $412 million.
- Impairment, restructuring and acquisition-related costs increased to $103 million from $19 million; litigation and investigation costs rose to $31 million from $5 million.
- Same-hospital revenue growth reflected stronger outpatient activity and managed-care pricing, offset by weaker inpatient volumes. Same-hospital doubtful-account provision increased 5.6%.
Outlook, commentary and risks
- Management expects 2014 capital expenditures of approximately $900 million to $1 billion. It estimated 2014 health-information-technology program expenses of about $145 million and expected EHR incentives of about $105 million.
- Management expects expanded insurance coverage under the Affordable Care Act to benefit providers over time, but said the net effect is uncertain due to Medicaid expansion decisions, reimbursement cuts, payer terms and implementation. Tenet noted that Florida and Texas had not chosen to expand Medicaid at the time of filing.
- Management emphasized successful Vanguard integration, cost control, outpatient growth, physician alignment and expansion of Conifer as priorities. No specific full-year earnings guidance is provided in the supplied filing text.
- Key risks include high leverage and refinancing needs, payer reimbursement and collection pressure, uninsured and underinsured care, labor shortages and union negotiations, regulatory and reimbursement changes, acquisition-integration execution, and potential further impairment charges. The credit facility also required repayment or refinancing of approximately $238 million of 2015 notes by November 3, 2014 to retain its scheduled 2016 maturity.
- Contingencies include pending government reviews involving kyphoplasty, ICD procedures and Clinica de la Mama arrangements; Tenet had recorded aggregate reserves of approximately $27 million for these matters, while outcomes and potential additional exposure remained uncertain. Conifer received a CFPB civil investigative demand concerning debt-collection activities and was cooperating.
- Management and the auditor concluded internal control over financial reporting was effective for the assessed operations, but Vanguard was excluded from the 2013 assessment and audit of controls; integration and evaluation were expected during 2014. The auditor gave an unqualified opinion on the financial statements.
Important facts for investors to verify
- Track post-acquisition results separately from legacy same-hospital trends, particularly inpatient volumes, outpatient growth and margins.
- Assess whether operating cash generation can support debt service, the 2014 capital-spending plan and upcoming maturities; verify revolver availability and covenant compliance.
- Monitor integration costs, realization of Vanguard synergies and final purchase-price allocations.
- Review changes in bad-debt expense, self-pay collection rates, payer mix and managed-care contract pricing.
- Follow the resolution and any reserve changes for government investigations, the CFPB inquiry and other litigation.
- Monitor Medicaid and Medicare payment changes, including DSH reductions, sequestration and quality-linked reimbursement.